Literature DB >> 12390496

Safety evaluation of sous vide-processed ready meals.

H Nissen1, J T Rosnes, J Brendehaug, G H Kleiberg.   

Abstract

AIMS: To assess survival, growth and toxin production of spore-forming bacteria in sous vide products exposed to a relatively high heat treatment. METHODS AND
RESULTS: During a three-year period, 2,168 sous vide-processed, commercially available ready-made meals with a shelf life of 3-5 weeks were examined. The products were stored at 4 degrees C for the first 1/3 and at 7 degrees C for the remaining 2/3 of their shelf life period. Three-fourths of the samples had less than 10 bacteria per gram the day after production, and none had more than 1,000. Similar numbers were found at the end of the shelf life when stored as described above. At abuse temperature (20 degrees C), the number of bacteria increased to 10(6)-10(7) cfu g(-1) 7 d after production. A total of 350 isolates of Bacillus spp. were collected, but no Clostridium strains were detected. Only 11 of the 113 tested strains were able to grow at 7 degrees C in broth, and none of the psychrotrophic strains were able to produce substantial amounts of toxins causing food poisoning.
CONCLUSION: The health risk of these products is small as long as the temperature during storage is low. For microbial testing of the end products, traditional plating will suffice.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12390496     DOI: 10.1046/j.1472-765x.2002.01218.x

Source DB:  PubMed          Journal:  Lett Appl Microbiol        ISSN: 0266-8254            Impact factor:   2.858


  2 in total

1.  An assessment of the microbiological quality of lightly cooked food (including sous-vide) at the point of consumption in England.

Authors:  F Jørgensen; L Sadler-Reeves; J Shore; H Aird; N Elviss; A Fox; M Kaye; C Willis; C Amar; E DE Pinna; J McLauchlin
Journal:  Epidemiol Infect       Date:  2017-02-27       Impact factor: 4.434

2.  Prognosis research strategy (PROGRESS) 1: a framework for researching clinical outcomes.

Authors:  Harry Hemingway; Peter Croft; Pablo Perel; Jill A Hayden; Keith Abrams; Adam Timmis; Andrew Briggs; Ruzan Udumyan; Karel G M Moons; Ewout W Steyerberg; Ian Roberts; Sara Schroter; Douglas G Altman; Richard D Riley
Journal:  BMJ       Date:  2013-02-05
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.